# The Boceprevir and Sildenafil Pharmacokinetics Study

> **NCT01499498** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 13 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sildenafil and Boceprevir

## Key facts

- **NCT ID:** NCT01499498
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2014-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499498, "The Boceprevir and Sildenafil Pharmacokinetics Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01499498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*